Literature DB >> 11420280

How apoptosis is regulated, and what goes wrong in cancer.

J Sjöström1, J Bergh.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11420280      PMCID： PMC1120577          DOI： 10.1136/bmj.322.7301.1538

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

Authors:  C Teixeira; J C Reed; M A Pratt
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

3.  Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma.

Authors:  J S Waters; A Webb; D Cunningham; P A Clarke; F Raynaud; F di Stefano; F E Cotter
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

Review 4.  Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.

Authors:  J C Reed
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

Review 5.  Apoptosis and therapy.

Authors:  C A Schmitt; S W Lowe
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

6.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

Review 7.  The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

Authors:  A Hamilton; M Piccart
Journal:  Ann Oncol       Date:  2000-06       Impact factor: 32.976

Review 8.  Clinical implications of p53 mutations.

Authors:  R R Wallace-Brodeur; S W Lowe
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

Review 9.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

10.  The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

Authors:  S Sjögren; M Inganäs; T Norberg; A Lindgren; H Nordgren; L Holmberg; J Bergh
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506
View more
  12 in total

1.  Terminology used in article on cloning was incorrect.

Authors:  P Millard
Journal:  BMJ       Date:  2001-10-06

Review 2.  The aging heart and post-infarction left ventricular remodeling.

Authors:  Henry Shih; Brian Lee; Randall J Lee; Andrew J Boyle
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

3.  Involvement of chromosome region maintenance 1 (CRM1) in the formation and progression of esophageal squamous cell carcinoma.

Authors:  Xiaojing Yang; Lei Cheng; Li Yao; Hanru Ren; Shu Zhang; Xiao Min; Xueyu Chen; Jianguo Zhang; Mei Li
Journal:  Med Oncol       Date:  2014-08-23       Impact factor: 3.064

4.  Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer.

Authors:  Xiao-Gang Shen; Cun Wang; Yuan Li; Bin Zhou; Bin Xu; Lie Yang; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2011-05-11       Impact factor: 2.571

5.  Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells.

Authors:  Harue Akasaka; Fuyuki Sato; Satoko Morohashi; Yunyan Wu; Yang Liu; Jun Kondo; Hiroki Odagiri; Kenichi Hakamada; Hiroshi Kijima
Journal:  BMC Cancer       Date:  2010-10-12       Impact factor: 4.430

6.  Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas.

Authors:  Temitope O Keku; Ahmad Amin; Joseph Galanko; Christopher Martin; Barbara Schliebe; Robert S Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

7.  ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA.

Authors:  Katrin Schelleckes; Boris Schmitz; Malte Lenders; Mirja Mewes; Stefan-Martin Brand; Eva Brand
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

8.  The anti-apoptotic protein lifeguard is expressed in breast cancer cells and tissues.

Authors:  Vesna Bucan; Kerstin Reimers; Claudia Yu Choi; Mau-Thek Eddy; Peter M Vogt
Journal:  Cell Mol Biol Lett       Date:  2010-03-19       Impact factor: 5.787

9.  BAX/BCL-2 mRNA and protein expression in human breast MCF-7 cells exposed to drug vehicles-methanol and dimethyl sulfoxide (DMSO) for 24 hrs.

Authors:  Gbenga Anthony Adefolaju; Kathrine E Theron; Margot Jill Hosie
Journal:  Niger Med J       Date:  2015 May-Jun

10.  FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.

Authors:  Paulo Bentes de Carvalho-Neto; Marcelo dos Santos; Marcos Brasilino de Carvalho; Ana Maria da Cunha Mercante; Viviane Priscila Pina dos Santos; Patrícia Severino; Eloiza Helena Tajara; Iuri Drumond Louro; Adriana Madeira Álvares da Silva-Conforti
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.